Literature DB >> 408322

In vitro studies with mecillinam on Escherichia coli and Pseudomonas aeruginosa.

M H Richmond.   

Abstract

The ability of a beta-lactam antibiotic to inhibit the growth of Gram-negative bacteria depends on three main properties: ting sites in the bacterial cell; the ability to penetrate through the outer layers of the bacterial envelope to these sites; and the ability to resist destruction by beta-lactamases that may be encountered on the way to the target. This article describes the properties of mecillinam with respect to the last two of these properties. Although able to hydrolyse mecillinam under some conditions, the beta-lactamases present in many Gram-negative species are unlikely to be very effective at protecting the bacteria in vivo because of their relatively low affinity for this penicillin and the good penetrative properties of the antibiotic.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 408322     DOI: 10.1093/jac/3.suppl_b.29

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  6 in total

1.  Effect of beta-lactamase and salt on mecillinam susceptibility of enterobacterial strains.

Authors:  G P Bongaerts; K M Bruggeman-Ogle
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

2.  Synergistic activity of mecillinam in combination with the beta-lactamase inhibitors clavulanic acid and sulbactam.

Authors:  H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

Review 3.  Penicillins--new insights into their mechanisms of activity and clinical use.

Authors:  H C Neu
Journal:  Bull N Y Acad Med       Date:  1982-11

4.  The role of beta-lactamase and the outer-membrane structure in the resistance of Enterobacteriaceae to mecillinam.

Authors:  G P Bongaerts; K Bruggeman-Ogle
Journal:  Antonie Van Leeuwenhoek       Date:  1980       Impact factor: 2.271

5.  What do beta-lactamases mean for clinical efficacy?

Authors:  H C Neu
Journal:  Infection       Date:  1983       Impact factor: 3.553

6.  In vitro antagonism of beta-lactam antibiotics by cefoxitin.

Authors:  C C Sanders; W E Sanders; R V Goering
Journal:  Antimicrob Agents Chemother       Date:  1982-06       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.